Seller record · healthhub.care

HealthHub

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S4, compounding disclosure: The semaglutide product page says compounded semaglutide delivers the same active compound as Ozempic and that some medications may be compounded, with no statement that compounded drugs are not FDA-approved. That statement appears only on the home page. 2 more criteria also fail; see the table below.

At a glance

HealthHubhealthhub.care

5/8criteria passed
Price
Semaglutide from $99, tirzepatide from $199
Sells
compounded semaglutide injection, sublingual and dissolving tablet, and 9 more
FDA letters
None on file
Visit HealthHubSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, sermorelin, NAD+ and PT-141 as one-time purchases with no subscription. It names six compounding pharmacies with street addresses and prints no business address.

Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASShealthhub.care, healthhub.care/faq
S2Prescription gatingPASSbook.healthhub.care
S3Pharmacy identificationPASShealthhub.care/contact, healthhub.care/products/semaglutide
S4Compounding disclosureFAILhealthhub.care/products/semaglutide, healthhub.care
S5Analytical documentationFAILhealthhub.care/faq
S6Business addressFAILhealthhub.care/contact, healthhub.care/legal/terms, healthhub.care/legal/privacy-policy
S7Price disclosurePASShealthhub.care/products/semaglutide, book.healthhub.care, healthhub.care/products/tirzepatide, healthhub.care/products/nad, healthhub.care/products/sermorelin
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA board-certified provider reviews each intake and sends a treatment plan by video or secure message, and treatment is prescribed only if a licensed provider finds it appropriate.Source: healthhub.care, healthhub.care/faq.
S2PASSThe order path puts a medical questionnaire and a scheduled video consultation before the payment step, and an order the provider does not approve is refunded.Source: book.healthhub.care.
S3PASSSix pharmacies are named with street addresses on the contact page and the product pages: AnazaoHealth, Tailor Made Compounding, Redrock Pharmacy, Professional Arts, Perfect RX and Vios Compounding Pharmacy. The home page describes an in-house pharmacy that none of these pages names.Source: healthhub.care/contact, healthhub.care/products/semaglutide.
S4FAILThe semaglutide product page says compounded semaglutide delivers the same active compound as Ozempic and that some medications may be compounded, with no statement that compounded drugs are not FDA-approved. That statement appears only on the home page.Source: healthhub.care/products/semaglutide, healthhub.care.
S5FAILNo certificate of analysis or lot document is published on the product pages, the answers or the legal pages.Source: healthhub.care/faq.
S6FAILNo business address is printed. The footer, the contact page, the terms and the privacy policy give only an email address, and the only street addresses on the site belong to the six pharmacies.Source: healthhub.care/contact, healthhub.care/legal/terms, healthhub.care/legal/privacy-policy.
S7PASSSemaglutide injection at $99 for a 4-week supply at the starting dose, rising to $249 at higher doses, and semaglutide sublingual at $149. Tirzepatide injection at $199, the NAD+ injection kit at $129 for 4 weeks and the sermorelin troche at $129, each a one-time purchase including consultation, medication and shipping.Source: healthhub.care/products/semaglutide, book.healthhub.care, healthhub.care/products/tirzepatide, healthhub.care/products/nad, healthhub.care/products/sermorelin.
S8PASSNo FDA warning letter names HealthHub, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, sublingual and dissolving tablet, compounded tirzepatide injection and dissolving tablet, sermorelin troche and sublingual dropper, NAD+ injection, nasal spray and patches, PT-141 injection, vitamin B12, low-dose naltrexone, methylene blue, oxytocin, testosterone.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells PT-141

Unpaid link. HealthHub does not pay the site, and nothing is earned when it is used. Funding.

Visit HealthHub

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.